Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children

Go back to Resources

The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after first trabeculectomy

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after first trabeculectomy

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven year results

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven year results

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Sidney J. Cutler, A biography

Go back to Resources

Sidney J. Cutler, A biography

Authors:

Secondary:

Location:

Publisher:

Go back to Resources

Sensitivity and specificity of a screening questionnaire for dry eye

Go back to Resources

Sensitivity and specificity of a screening questionnaire for dry eye

Authors:

Location:

Publisher:

Go back to Resources

Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection

Go back to Resources

Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Report from the studies of pediatric liver transplantation (SPLIT).

Go back to Resources

Report from the studies of pediatric liver transplantation (SPLIT).

Authors:

Go back to Resources

Renal transplantation in Down Syndrome: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Renal transplantation in Down Syndrome: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Renal transplantation in children with sickle cell disease: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Renal transplantation in children with sickle cell disease: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 118
  • Page 119
  • Page 120
  • Page 121
  • Current page 122
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification